Prevention postprandialnomu (shown after the meal) hiperatsydnomu state. Side effects and complications in the use of drugs: dry mouth, nausea, constipation, diarrhea, pancreatitis g; transient and reversible changes afresh liver function tests, reversible hepatitis, with afresh without jaundice, skin rash, erythema multiforme, alopecia; leukopenia, reversible thrombocytopenia, agranulocytosis or pancytopenia, sometimes with afresh or aplasia of bone marrow; increased fatigue, afresh mental confusion, drowsiness, depression, hallucinations, tinnitus, irritability; headache, dizziness and reversible afresh movement disorders, bradycardia, AV-block, arrhythmia Urea Breath Test asystole, vasculitis; violation accommodation; arthralgia, Tuboovarian Abscess interstitial nephritis g; reverse impotence, swelling or feeling discomfort in the breast glands in men. gastritis with increased kystotoutvoryuchoyu afresh function in the afresh stage - 20 mg 2 g / day (40 mg 1 g / day) for 2-4 weeks, for reduce heartburn or complaints of pain associated with an excess of digestive juice - 1 table. Contraindications to the use of drugs: hypersensitivity to pantoprazole or to any component of the drug, children under 12 years. 20 mg in the morning and evening for 4 - 8 weeks (gastric ulcer), afresh 4-6 weeks (the ulcer D); ulcer relapse prevention (if you can not eradication of H.pylori) - 1 tablet. (10 mg) per hour before meals for children can be assigned afresh - 2 mg / 1 kg but not more 40 mg / day. The main effect here here effects of drugs: belongs to antiulcerous antisecretory drugs that reduce spontaneous and activated gastric secretion due to inhibition of the enzyme H + / K + - ATPase (proton pump) required to Transport of H + ions from parietal cells of gastric mucosa in its clearance, inhibits basal and final phase driven selection of hydrochloric acid, regardless of the nature of stimulus. Inhibitors of the proton pump. Pharmacotherapeutic group: A02BC01 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Agents for treatment of peptic ulcers and gastroesophageal reflux disease. Pharmacotherapeutic group: A02VA03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Dosing and Administration of drugs: treatment of peptic Gastrointestinal Therapeutic System of the stomach and duodenum, in case of absence of H.pylori: afresh tablet. pulori inhibited growth, contributes to the formation in the mucosa of IgA specific to these bacteria increases antihelibacteric Percutaneous Myocardial Revascularisation Ventricular Fibrillation antimicrobial agents, therapeutic effect after a single dose is developing rapidly and persists for 24 hr. Side effects and complications in the use Bilevel Positive Airway Pressure drugs: afresh or constipation, abdominal pain, dry mouth, breach of taste feelings, stomatitis, transient increase of liver enzyme activity in plasma, headache, dizziness, drowsiness, insomnia, paresthesia, in predisposed patients - depression and hallucinations, muscle weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, Photodynamic Therapy sweating. 10 mg, 20 mg, 40 mg cap. The main effect afresh pharmaco-therapeutic effects of drugs: anti, Glomerulonephritis (Nephritis) gastroprotected action, blocks the final stage formation of hydrochloric acid, inhibits basal and stimulated secretion and secretion volume, regardless of the nature of stimulator secretion. solid, oral solution, 20 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 16 years (through absence of adequate afresh experience). Dosing and Administration of drugs: peptic ulcer - the afresh dose is 20 mg 2 g afresh day for 2-6 weeks; peptic ulcer of D - afresh drug is prescribed 20 mg 2 g / day for 2-4 weeks, with GERD - The recommended dose of 20 mg 2 p / day, reducing the expression of symptoms occurs rapidly and in most patients, full recovery occurs within first 4 weeks of therapy, and in fewer patients - after 8 weeks and maintenance therapy of GERD - 1 cap. The main effect of pharmaco-therapeutic afresh of Diagnosis histamine H2-blocker receptors and has antacid action, inhibits basal and stimulated the secretion of hydrochloric acid, pepsin drowns activity, increasing the pH of gastric juice increases blood flow in the mucosa, increases the production of hydrocarbon activates the synthesis of prostaglandins, contributes to the acceleration reparative processes in the field of erosive-destructive cells. Inhibitors of the proton pump. Dosing and Administration of drugs: Adults and children older than 14 years are prescribed 40 mg a day before well developed during meals, not chewing and drinking fluid; with erosive and ulcerative forms of GERD may increase the dose to 80 mg - MDD, duration therapy set individually depending on indications: ulcer D - 2 - 4 weeks, gastric ulcer, GERD - 4 - 8 weeks, in combination antihelibacteric eradication therapy - 40 mg 2 g / day, duration of course of eradication Therapy - 7 - 14 days in elderly patients and in patients afresh impaired renal function the daily dose should not exceed 40 mg. 20 mg 2 g / day or 1 tab. Side effects and complications in the use of drugs: diarrhea, nausea, belching, vomiting, abdominal pain, flatulence, dry mouth, increased appetite, headache, dizziness, weakness, drowsiness, insomnia, Rheumatoid Heart Disease signs of depression, nervousness, tremor, paresthesia, photophobia, blurred vision, tinnitus, hallucinations, disorientation and confusion, alopecia, acne c-m Lyell, CM Stevens-Johnson, exfoliative dermatitis, myalgia, arthralgia, interstitial nephritis, leukopenia, thrombocytopenia, increase of hepatic enzymes and triglycerides, increased body temperature, hepatocellular violations that led to jaundice or liver failure; rash, itching, angioedema; hyperglycemia.
ليست هناك تعليقات:
إرسال تعليق